Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
cell therapeutics (uk)
cell therapeutics (uk)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
cell therapeutics (uk) ltd
cell therapeutics (uk) ltd
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
amicus therapeutics uk ltd
amicus therapeutics uk, ltd
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
irland: clinical pharmacology and therapeutics
irland: clinical pharmacology and therapeutics
Last Update: 2014-10-23
Usage Frequency: 1
Quality:
amicus therapeutics, uk ltd tel: + 1800936230
amicus therapeutics, uk ltd tlf.: + 1800936230
Last Update: 2017-04-26
Usage Frequency: 16
Quality:
amicus therapeutics bv tel: + 31 20 235 8510
amicus therapeutics bv tlf.: + 31 20 235 8510
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
amicus therapeutics gmbh tel: + 49 89 20 802 6527
amicus therapeutics gmbh tlf.: + 49 89 20 802 6527
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
amicus therapeutics, uk ltd tel: + 08-082346864
det forenede kongerige amicus therapeutics, uk ltd tlf.: + 08-082346864
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
der inhaber der genehmigung für das inverkehrbringen ist ino therapeutics ab.
indehaveren af markedsføringstilladelsen er ino therapeutics ab.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
pharmazeutischer unternehmer ino therapeutics ab se-181 81 lidingö schweden
indehaver af markedsføringstilladelsen ino therapeutics ab se- 181 81 lidingö sverige
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
amicus therapeutics, uk ltd puh/tel: + 0800-9-17780
amicus therapeutics, uk ltd puh/tlf.: + 0800-9-17780
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
name und anschrift des herstellers des wirkstoffs biologischen ursprungs united therapeutics corporation
navn og adresse på fremstilleren af det biologisk aktive stof united therapeutics corporation
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
luxembourg/luxemburg amicus therapeutics, uk ltd tél/tel: + 8002-7003
luxembourg/luxemburg amicus therapeutics, uk ltd tél/tlf.: + 8002-7003
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
1 coetzee et al., 2007, journal of veterinary pharmacology & therapeutics, 30, 4, 305-319.
1 coetzee et al, 2007, journal of veterinary pharmacology & therapeutics, 30, 4, 305- 319.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
Warning: This alignment may be wrong.
Please delete it you feel so.
belgië/belgique/belgien amicus therapeutics, uk ltd tél/tel: + 0800-79245
belgique/belgië/belgien amicus therapeutics, uk ltd tél/tlf.: + 0800-79245
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
genzyme therapeutics ltd, 4620 kingsgate, cascade way, oxford business park south, oxford, ox4 2su, vereinigtes königreich.
genzyme therapeutics ltd, 4620 kingsgate, cascade way, oxford business park south, oxford, ox4 2su, storbritannien
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
marcin szumowski (berichterstatter) (pl), präsident & ceo, oncoarendi therapeutics, gründer, btm mazovia.
marcin szumowski (rapportør) (pl), direktør og administrerende direktør, oncoarendi therapeutics, grundlægger, btm mazovia.
Last Update: 2017-04-07
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
18 sicherheit die therapeutic arthritis research and gastrointestinal event trial studie (target) target ist eine 12-monatige, doppelblinde, phase iii studie mit 18.325 arthrosepatienten, die auf 400 mg lumiracoxib 1mal täglich (das 2 bis 4fache der empfohlenen dosis bei arthrosepatienten), 500 mg naproxen 2mal täglich oder 800 mg ibuprofen 3mal täglich randomisiert wurden.
sikkerhed the therapeutic arthritis research and gastrointestinal event trial (target) target, et 12 måneders, dobbeltblindet, fase iii studie inkluderende 18. 325 osteoarthrose patienter randomiseret til lumiracoxib 400 mg én gang daglig (to til fire gange den anbefalede dosis), naproxen 500 mg to gange daglig eller ibuprofen 800 mg tre gange daglig.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.